大行評級|里昂:上調零跑汽車目標價至54港元 預期新車型帶動今年總銷量達50萬輛
里昂發表研究報吿指,留意到零跑汽車在高級駕駛輔助系統技術上的快速進步,而其渠道調查顯示,強勁的訂單有望支持其快速的銷量增長。公司計劃在今明兩年內推出B、D和A系列車型,進一步豐富零跑在大眾電動車市場的產品密度,增強其市場競爭力。該行預計2026年起,海外業務將對盈利做出實質性貢獻。而公司擁有強大的內部研發能力,這將幫助其持續通過技術升級實現成本降低;在高級駕駛輔助系統技術發展趨勢上,公司有望跟隨行業領先者的步伐。該行將公司目標價從40.6港元上調至54港元,並重申“跑贏大市”評級。該行料新車型的銷售會帶動今年總銷量達50萬輛,並在今年達到收支平衡。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.